APPARATUS AND METHODS FOR CONTROLLED ISCHEMIC CONDITIONING

• US 20100185220A1
• Filed: 05/23/2008
• Published: 07/22/2010
• Est. Priority Date: 05/23/2007
• Status: Abandoned Application

• Current Assignee: IC Therapeutics, Inc.
• Original Assignee: IC Therapeutics, Inc.
• Inventors: Naghavi, Morteza, Yen, Albert Andrew, Hassan, Haider, Panthagani, David
• Application Number:
  US12/601,391
• Publication Number:
  US 20100185220A1
• Time in Patent Office: Days
• US Class Current: 606/158
• CPC Class Codes: A61B 17/12009 Implements for ligaturing other than by clamps or clips, e.g. using a loop with a slip knot
• CPC Class Codes: A61B 2017/2808 Clamp, e.g. towel clamp
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/412 Detecting or monitoring sepsis
• CPC Class Codes: A61B 5/418 lymph vessels, ducts or nodes

Abstract

Methods and apparatus for ischemic conditioning treatment in a patient are provided. Transient ischemia is caused by interrupting blood flow to a tissue. Markers of ischemia and metabolism are monitored in the tissue and the induced ischemia is adjusted based on the monitoring results.

Claims

1. An instrument for inducing ischemic conditioning by controlled extravascular occlusion, comprising:

at least one occluding member adapted to partially or completely surround at least one blood vessel, and

a controller operably connected to the at least one occluding member, wherein the controller is adapted to remotely control occlusion and release of the blood vessel by the at least one occluding member.

2. The instrument of claim 1, wherein the controller is operably connected to the at least one occluding member by a wireless connection.

3. The instrument of claim 1, further comprising one ore more sensors operably connected to the controller and adapted to detect sensed markers of ischemia, blood flow, or metabolism, and combinations thereof.

4. The instrument of claim 3 wherein the sensed markers of ischemia include one or more of tissue oxygenation, and levels of hemoglobin, and the sensed markers of metabolism include one ore more of lactate, pH, oxygen, carbon dioxide, ATP, ADP, adenosine, cytochrome oxidase, redox voltage, erythropoietin, bradykinin, and opioids.

5. The instrument of claim 3 wherein the controller is a programmable controller that remotely controls extent, duration, frequency, and combinations thereof, of occlusion and release of a flow of blood through the luminal tissue based on feedback from the one or more sensors.

6. The instrument of claim 1 wherein the occluding member is a clamp that is pistoned, jawed, coiled, inflatable, steerable, ringed, or capable of timed release, and combinations thereof.

7. The instrument of claim 5 wherein the programmable controller is a mechanical controller or an electromagnetic controller, or a combination thereof.

8. The instrument of claim 6 wherein the clamp is biodegradable.

9. The instrument of claim 1 wherein the occluding member has the capability to be guided to, positioned on, and tightened around a luminal tissue that is not a blood vessel.

10. The instrument of claim 5 wherein the controller is implanted subcutaneously.

11. The instrument of claim 1 wherein the occluding member is capable of surrounding more than one blood vessel at the same time.

12. The instrument of claim 1 wherein the occlusion and release by the occluding member is manual, automated, or combinations thereof.

13. The instrument of claim 1, wherein the occluding member is an inflatable clamp and the instrument further comprises a pump operably connected to the occluding member to inflate the inflatable clamp to sustain partial or complete occlusion of the blood vessel.

14. The instrument of claim 1 wherein the clamp is adapted and programmed to sustain partial occlusion of a blood supply or alternatively completely occlude the blood supply based on the sensed markers.

15. An instrument for inducing ischemic conditioning in a tissue by controlled intravascular occlusion of one or more blood vessels feeding the tissue, comprising:

an occluding member;

a sensor disposed distal to the occluding member and adapted to detect one or more of;

markers of ischemia or metabolism, and combinations thereof in the tissue; and

a programmable controller operably connected to the occluding member and the sensor and adapted to control the occlusion and release of the blood vessel by the occluding member based on the sensed markers.

16. The instrument of claim 15, wherein the occluding member is a inflatable balloon and further comprising a puncturing device, an angioplasty balloon catheter, or combinations thereof, attached to the occluding member.

17. The instrument of claim 15, wherein the occluding member is adapted to reduce or prevent exiting venous blood outflow.

18. The instrument of claim 15, wherein the occlusion and release by the occluding member is manual, automated, or combinations thereof.

19. The instrument of claim 15, wherein the occluding member is adapted to induce controlled reperfusion.

20. The instrument of claim 15, wherein the occluding member is adapted to sustain controlled reperfusion according to a schedule, wherein the schedule is selected from one or more of:

a sinusoidal schedule, a linear schedule, or an on and off schedule with an off time of less than 5 seconds.

21. The instrument of claim 15, further comprising a blood flow sensor disposed distal to the occluding member.

22. The instrument of claim 15, further comprising a pump operably connected to the programmable controller and adapted to occlude the occluding member based on the sensed markers.

23. The instrument of claim 15, wherein the sensed markers of ischemia include one or more of tissue oxygenation, and levels of hemoglobin, and the sensed markers of metabolism include one ore more of lactate, pH, oxygen, carbon dioxide, ATP, ADP, adenosine, cytochrome oxidase, redox voltage, erythropoietin, bradykinin, and opioids.

24. A method for ischemic conditioning in a patient using an extravascular occlusion, comprising:

guiding an occluding instrument having at least one interior space to a blood vessel of the patient,

positioning the occluding instrument around the blood vessel,

compressing the blood vessel with the occluding instrument to induce at least a partial occlusion,

decompressing the blood vessel to at least a partial release, and

remotely controlling the occlusion and decompressing by the occluding instrument.

25. The method of claim 24, further comprising a step of sensing markers of ischemia, blood flow, or metabolism, and combinations thereof in tissue perfused by the blood vessel.

26. The method of claim 25, further comprising remotely controlling an extent, duration, frequency, or combinations thereof of occlusion and decompressing based on the sensed markers.

27. The method of claim 25 wherein the sensed markers of ischemia include one or more of tissue oxygenation, and levels of hemoglobin, and the sensed markers of metabolism include one ore more of lactate, pH, oxygen, carbon dioxide, ATP, ADP, adenosine, cytochrome oxidase, redox voltage, erythropoietin, bradykinin, and opioids.

28. The method of any of claims 24-27 wherein the ischemic conditioning is adapted to one or more of inducing collaterals or angiogenesis, inducing necrosis, reducing reperfusion injury, or combinations thereof.

29. The method of claim 24 wherein the occlusion is extraluminal and the instrument is guided to, positioned around, and compresses a lumen of the body that is not a blood vessel.

30. The method of claim 24 wherein the ischemic conditioning is administered to reduce complications of cardiothoracic surgery, vascular surgery, gastrointestinal surgery, use of contrast dye, transplants, implants, or grafting, and combinations thereof.

31. The method of claim 24 wherein more than one blood vessel are occluded at the same time by the instrument.

32. A method for intravascular occlusion in a patient comprising:

guiding an instrument to a blood vessel in the patient,

positioning the instrument to contact the blood vessel at an occlusion site,

causing ischemia by interrupting blood flow to a tissue distal to the occlusion site,

monitoring markers of ischemia and/or metabolism in the tissue distal to the occlusion site, and

adjusting the ischemia based on the monitoring results.

33. A method for preventing, minimizing, or reducing reperfusion injury by controlling reperfusion to a target tissue based on measurements of metabolic markers of ischemia in the target tissue.

34. The method of claim 33, wherein the controlled reperfusion is effected by modulations of blood flow, including waveforms of flow rate that are linear, sinusoidal, squared, triangle, sawtoothed, or combinations thereof.

35. The method of claim 33 wherein the target tissue that is monitored is distal to the site of reperfusion.

36. The method of claim 33, further comprising administering a preconditioning procedure prior to controlling reperfusion.

37. The method of claim 33, wherein reperfusion injury is prevented, minimized, or reduced without measurements of the target tissue, but the reperfusion flow rate is maintained below uncontrolled, hyperemic levels without reaching a no-flow state.